Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Dendritic cells and tumor immunity.

M Gunzer1, S Jänich, G Varga

  • 1Department of Dermatology, University of Münster, Von-Esmarch-Str 58, D-48149 Münster, Germany.

Seminars in Immunology
|August 15, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Oral Burden of Sjögren Disease: A Systematic Review and Meta-analysis.

Journal of dental research·2026
Same author

IO102-IO103 immune-modulatory cancer vaccine and pembrolizumab in melanoma.

Annals of oncology : official journal of the European Society for Medical Oncology·2026
Same author

Safety and efficacy of maxillomandibular fixation techniques: a network meta-analysis.

International journal of oral and maxillofacial surgery·2025
Same author

Phagocytic cell death leads to enhanced release of pro-inflammatory S100A12 in familial Mediterranean fever.

Molecular and cellular pediatrics·2023
Same author

Self-management-competency as a new target in Hidradenitis suppurativa care.

The Journal of dermatological treatment·2023
Same author

Urinary tract infections in patients with multiple sclerosis and different methods of bladder evacuation.

Actas urologicas espanolas·2022

Dendritic cells (DCs) show promise for cancer immunotherapy by presenting tumor antigens to T cells. However, clinical trials show limited success, highlighting the need for further research into DC biology and immune induction mechanisms.

Area of Science:

  • Immunology
  • Oncology
  • Biotechnology

Background:

  • Decades of research have explored using immune system mechanisms to combat cancer.
  • Early strategies involved soluble immune mediators like antibodies and cytotoxic proteins.
  • Advances in cellular immunity have enabled the generation of cancer-specific effector cells.

Purpose of the Study:

  • To review the current state of dendritic cell (DC) based cancer immunotherapy.
  • To discuss conceptual approaches, techniques, and challenges in the field.
  • To highlight the potential of DCs in inducing tumor immunity.

Main Methods:

  • Review of existing literature on DC biology and immunotherapy.
  • Analysis of clinical studies involving DC-based cancer treatments.

Related Experiment Videos

  • Discussion of antigen presentation by DCs to T cells for immune activation.

    • Main Results:

    • Dendritic cells (DCs) are potent antigen-presenting cells crucial for initiating cellular immune responses against cancer.
    • In vitro generation and manipulation of DCs offer a promising approach for cancer immunotherapy.
    • Initial clinical studies using DCs have yielded limited success, indicating unresolved challenges.

    Conclusions:

    • Despite challenges, DCs hold significant potential for inducing tumor-specific immunity.
    • Further research into DC biology and immune induction is essential for effective cancer immunotherapy.
    • The next few years are critical for advancing DC-based cancer treatment strategies.